February 10, 2025
Fresenius Kabi Introduces Calcitonin Salmon Injection, USP Synthetic
Fresenius Kabi, an operating company of Fresenius, announced today it has introduced Calcitonin Salmon Injection, USP Synthetic, a calcium regulator, for the treatment of symptomatic Paget’s disease of the bone and hypercalcemia.